Potent inhibition of human immunodeficiency virus type 1 replication by conditionally replicating human immunodeficiency virus-based lentiviral vectors expressing envelope antisense mRNA

Human Gene Therapy

Volumn 11, Issue 14, 2000, Pages 2025-2037

  Mautino, M R ^a   Morgan, R A ^a  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN P24; COMPLEMENTARY RNA; MESSENGER RNA;

ARTICLE; EXPRESSION VECTOR; GENE DELETION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LENTIVIRINAE; NONHUMAN; PLASMID; PROTEIN SYNTHESIS INHIBITION; VIROGENESIS; VIRUS INFECTIVITY; VIRUS INHIBITION; VIRUS PARTICLE;

BLOTTING, NORTHERN; BLOTTING, SOUTHERN; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENETIC VECTORS; HIV-1; LENTIVIRUS; MODELS, GENETIC; OLIGONUCLEOTIDES, ANTISENSE; PLASMIDS; POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS; TRANSDUCTION, GENETIC; TRANSFECTION; VIRAL ENVELOPE PROTEINS;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRUS; RNA VIRUSES;

EID: 0034692440     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430340050143444     Document Type: Article

References (30)

1. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone
2. An inducible human immunodeficiency virus type 1 (HIV-1) vector which effectively suppresses HIV-1 replication
3. A new antisense tRNA construct for the genetic treatment of human immunodeficiency virus type 1 infection
4. Interaction of human immunodeficiency virus-derived vectors with wild-type virus in transduced cells
5. HIV-1 reverse transcription. A termination step at the center of the genome
6. Inhibition of human immunodeficiency virus type-1 by retroviral vectors expressing antisense-TAR
7. Inhibition of HIV-1 multiplication in a human CD4+ lymphocytic cell line expressing antisense and sense RNA molecules containing HIV-1 packaging signal and Rev response element(s)
8. Anti-HIV effects of HIV vectors
9. Reduction in SIV replication in rhesus macaques infused with autologous lymphocytes engineered with antiviral genes
10. A conditionally replicating HIV-1 vector interferes with wild-type HIV-1 replication and spread
11. A third-generation lentivirus vector with a conditional packaging system
12. Transfer of an anti-HIV-1 ribozyme gene into primary human lymphocytes
13. Gene therapy targeting cord blood-derived CD34+ cells from HIV-exposed infants: Preclinical studies
14. Stable human immunodeficiency virus type 1 (HIV-1) resistance in transformed CD4+ monocytic cells treated with multitargeting HIV-1 antisense sequences incorporated into U1 snRNA
15. Modified HIV-based lentiviral vectors display decreased sensitivity to transdominant
16. Improved retroviral vectors for gene transfer and expression
17. Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus
18. Gene therapy for AIDS using retroviral mediated gene transfer to deliver HIV-1 antisense TAR and transdominant Rev protein genes to syngeneic lymphocytes in HIV-1 infected identical twins
19. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector
20. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector
21. Analysis of trans-dominant mutants of the HIV type 1 Rev protein for their ability to inhibit Rev function. HIV type 1 replication, and their use as anti-HIV gene therapeutics
22. Inhibition of human immunodeficiency virus type 1 by Tat/Rev-regulated expression of cytosine deaminase, interferon alpha2, or diphtheria toxin compared with inhibition by transdominant
23. Enhanced T cell engraftment after retroviral delivery of an antiviral gene in HIV-infected individuals
24. Transduction of non-dividing cells using pseudotyped defective high-titer HIV type 1 particles
25. Sequence of the promoter region of the gene for human X-linked 3-phosphoglycerate kinase
26. Expression of naturally occurring antisense RNA inhibits human immunodeficiency virus type 1 heterologous strain replication
27. Interleukin-2-transduced lymphocytes grow in an autocrine fashion and remain responsive to antigen
28. Inhibition of clinical human immunodeficiency virus (HIV) type 1 isolates in primary CD4+ T lymphocytes by retroviral vectors expressing anti-HIV genes
29. Comparative analyses of intracellularly expressed antisense RNAs as inhibitors of human immunodeficiency virus type 1 replication
30. A controlled, phase 1 clinical trial to evaluate the safety and effects in HIV-1 infected humans of autologous lymphocytes transduced with a ribozyme that cleaves HIV-1 RNA